Talzenna 0.25 mg hard capsules

Company
Pfizer Healthcare Ireland Unlimited Company
Active Ingredient
Dosage Form
Capsule, hard
Legal Category
A - prescription, may not be renewed
Date of revision
06/2025

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/19/1377/001 0.25 milligram(s) L01XK, L01XK04 Capsule, hard
EU/1/19/1377/002 0.25 milligram(s) L01XK, L01XK04 Capsule, hard
EU/1/19/1377/003 0.25 milligram(s) L01XK, L01XK04 Capsule, hard
EU/1/19/1377/004 0.25 milligram(s) L01XK, L01XK04 Capsule, hard
Licence number
EU/1/19/1377/001
Strength
0.25 milligram(s)
ATC Code
L01XK, L01XK04
Dosage Form
Capsule, hard
Licence number
EU/1/19/1377/002
Strength
0.25 milligram(s)
ATC Code
L01XK, L01XK04
Dosage Form
Capsule, hard
Licence number
EU/1/19/1377/003
Strength
0.25 milligram(s)
ATC Code
L01XK, L01XK04
Dosage Form
Capsule, hard
Licence number
EU/1/19/1377/004
Strength
0.25 milligram(s)
ATC Code
L01XK, L01XK04
Dosage Form
Capsule, hard

Pfizer Healthcare Ireland Unlimited Company

The Watermarque Building, Ringsend Road, Dublin 4, D04 K7N3, Ireland, D04 K7N3 Dublin

Website
https://www.pfizermedicalinformation.ie/
Telephone
+3531800633363